

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 9.37036138 |
| 2 | exogenous drug catabolic process (GO:0042738) | 9.18078963 |
| 3 | drug catabolic process (GO:0042737) | 8.75423899 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 8.64044942 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 8.59002467 |
| 6 | * regulation of protein activation cascade (GO:2000257) | 8.46786396 |
| 7 | regulation of fibrinolysis (GO:0051917) | 8.01835445 |
| 8 | * regulation of complement activation (GO:0030449) | 7.98193225 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.78230646 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 7.78230646 |
| 11 | negative regulation of fibrinolysis (GO:0051918) | 7.68246815 |
| 12 | glyoxylate metabolic process (GO:0046487) | 7.50416361 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.20337120 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 7.20337120 |
| 15 | urea metabolic process (GO:0019627) | 6.88622907 |
| 16 | ethanol oxidation (GO:0006069) | 6.68958643 |
| 17 | protein carboxylation (GO:0018214) | 6.57684342 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.57684342 |
| 19 | nitrogen cycle metabolic process (GO:0071941) | 6.27084184 |
| 20 | drug metabolic process (GO:0017144) | 6.26357336 |
| 21 | blood coagulation, intrinsic pathway (GO:0007597) | 6.18237501 |
| 22 | fibrinolysis (GO:0042730) | 6.14163148 |
| 23 | cellular glucuronidation (GO:0052695) | 5.96138923 |
| 24 | bile acid biosynthetic process (GO:0006699) | 5.95817584 |
| 25 | urea cycle (GO:0000050) | 5.88517583 |
| 26 | oxidative demethylation (GO:0070989) | 5.81769988 |
| 27 | uronic acid metabolic process (GO:0006063) | 5.66034255 |
| 28 | glucuronate metabolic process (GO:0019585) | 5.66034255 |
| 29 | aromatic amino acid family catabolic process (GO:0009074) | 5.65786315 |
| 30 | * protein activation cascade (GO:0072376) | 5.63340681 |
| 31 | * complement activation (GO:0006956) | 5.44459020 |
| 32 | ethanol metabolic process (GO:0006067) | 5.39508713 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.38365745 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 5.33270992 |
| 35 | bile acid metabolic process (GO:0008206) | 5.29515499 |
| 36 | * complement activation, classical pathway (GO:0006958) | 5.29308866 |
| 37 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.14519475 |
| 38 | opsonization (GO:0008228) | 5.06649068 |
| 39 | acute-phase response (GO:0006953) | 5.05932143 |
| 40 | imidazole-containing compound metabolic process (GO:0052803) | 5.01638805 |
| 41 | negative regulation of cholesterol transport (GO:0032375) | 4.98317244 |
| 42 | negative regulation of sterol transport (GO:0032372) | 4.98317244 |
| 43 | * regulation of humoral immune response (GO:0002920) | 4.98213131 |
| 44 | phenylpropanoid metabolic process (GO:0009698) | 4.97684638 |
| 45 | regulation of plasminogen activation (GO:0010755) | 4.97322666 |
| 46 | bile acid and bile salt transport (GO:0015721) | 4.74391982 |
| 47 | glycine metabolic process (GO:0006544) | 4.69957832 |
| 48 | negative regulation of hemostasis (GO:1900047) | 4.65184789 |
| 49 | negative regulation of blood coagulation (GO:0030195) | 4.65184789 |
| 50 | cytolysis (GO:0019835) | 4.59929300 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.59710428 |
| 52 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.54747489 |
| 53 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.54747489 |
| 54 | * negative regulation of protein activation cascade (GO:2000258) | 4.54522638 |
| 55 | S-adenosylmethionine metabolic process (GO:0046500) | 4.49964237 |
| 56 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.47398295 |
| 57 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.38380733 |
| 58 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.38380733 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.35426389 |
| 60 | triglyceride homeostasis (GO:0070328) | 4.35426389 |
| 61 | negative regulation of coagulation (GO:0050819) | 4.24303055 |
| 62 | negative regulation of wound healing (GO:0061045) | 4.23604759 |
| 63 | hormone catabolic process (GO:0042447) | 4.21349622 |
| 64 | protein-lipid complex remodeling (GO:0034368) | 4.17913812 |
| 65 | macromolecular complex remodeling (GO:0034367) | 4.17913812 |
| 66 | plasma lipoprotein particle remodeling (GO:0034369) | 4.17913812 |
| 67 | glutamate metabolic process (GO:0006536) | 4.13414307 |
| 68 | amino-acid betaine metabolic process (GO:0006577) | 4.07873065 |
| 69 | alkaloid metabolic process (GO:0009820) | 4.04635914 |
| 70 | cholesterol efflux (GO:0033344) | 4.04372616 |
| 71 | positive regulation of blood coagulation (GO:0030194) | 4.03378209 |
| 72 | positive regulation of hemostasis (GO:1900048) | 4.03378209 |
| 73 | flavonoid metabolic process (GO:0009812) | 3.88671515 |
| 74 | phospholipid efflux (GO:0033700) | 3.87681064 |
| 75 | arginine metabolic process (GO:0006525) | 3.84956252 |
| 76 | intestinal cholesterol absorption (GO:0030299) | 3.84517045 |
| 77 | alpha-amino acid catabolic process (GO:1901606) | 3.83930334 |
| 78 | high-density lipoprotein particle remodeling (GO:0034375) | 3.82304526 |
| 79 | serine family amino acid metabolic process (GO:0009069) | 3.77626300 |
| 80 | acute inflammatory response (GO:0002526) | 3.77421269 |
| 81 | indole-containing compound catabolic process (GO:0042436) | 3.76946909 |
| 82 | indolalkylamine catabolic process (GO:0046218) | 3.76946909 |
| 83 | tryptophan catabolic process (GO:0006569) | 3.76946909 |
| 84 | regulation of cholesterol esterification (GO:0010872) | 3.76839882 |
| 85 | regulation of apoptotic cell clearance (GO:2000425) | 3.73255805 |
| 86 | positive regulation of coagulation (GO:0050820) | 3.71889068 |
| 87 | aromatic amino acid family metabolic process (GO:0009072) | 3.71641334 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.67037944 |
| 89 | response to mercury ion (GO:0046689) | 3.57023267 |
| 90 | * regulation of acute inflammatory response (GO:0002673) | 3.52153846 |
| 91 | xenobiotic metabolic process (GO:0006805) | 3.48099347 |
| 92 | reverse cholesterol transport (GO:0043691) | 3.47153630 |
| 93 | heme transport (GO:0015886) | 3.46712946 |
| 94 | sodium-independent organic anion transport (GO:0043252) | 3.45109637 |
| 95 | steroid catabolic process (GO:0006706) | 3.44845370 |
| 96 | cellular ketone body metabolic process (GO:0046950) | 3.43545872 |
| 97 | * negative regulation of complement activation (GO:0045916) | 3.42270026 |
| 98 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.36961720 |
| 99 | serine family amino acid biosynthetic process (GO:0009070) | 3.34836943 |
| 100 | cysteine metabolic process (GO:0006534) | 3.34434256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.79319845 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.77620764 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.63537970 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.63005295 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.10275988 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.80175337 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.34247878 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.96854283 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.85932138 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.91174216 |
| 11 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.17982898 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09679328 |
| 13 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.06141580 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.03025023 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.0366606 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.67233714 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.62509705 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.48409908 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34883190 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.31861925 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31173276 |
| 22 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28693012 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26290333 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.25988233 |
| 25 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23612359 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.22017091 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20898971 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09043617 |
| 29 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05048739 |
| 30 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98834850 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.98564653 |
| 32 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97855225 |
| 33 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97540260 |
| 34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97029364 |
| 35 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96975405 |
| 36 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95041524 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94306403 |
| 38 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91997759 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89666920 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88957630 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88900971 |
| 42 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.87460152 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86694258 |
| 44 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.83657700 |
| 45 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83279282 |
| 46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82616626 |
| 47 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.81596267 |
| 48 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.79697262 |
| 49 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79669165 |
| 50 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.79387475 |
| 51 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78400493 |
| 52 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77410684 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76675711 |
| 54 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76193016 |
| 55 | CBP_21632823_ChIP-Seq_H3396_Human | 0.75039297 |
| 56 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.74057917 |
| 57 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73981065 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.73191891 |
| 59 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.72682684 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.72265909 |
| 61 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.71671722 |
| 62 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.71237533 |
| 63 | AR_20517297_ChIP-Seq_VCAP_Human | 0.69596118 |
| 64 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.67878308 |
| 65 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67195922 |
| 66 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66705987 |
| 67 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66478957 |
| 68 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.66072104 |
| 69 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.64691062 |
| 70 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.64174744 |
| 71 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.63045193 |
| 72 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.62943134 |
| 73 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.62307367 |
| 74 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.61308486 |
| 75 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.61007351 |
| 76 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.60175589 |
| 77 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.59445929 |
| 78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.59328180 |
| 79 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.59000810 |
| 80 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.58691010 |
| 81 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.58507631 |
| 82 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.58357474 |
| 83 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.56932492 |
| 84 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.56845417 |
| 85 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.56623507 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.56502541 |
| 87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.56502541 |
| 88 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.56132701 |
| 89 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54499382 |
| 90 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.54282028 |
| 91 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.54071496 |
| 92 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.51451604 |
| 93 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.50604944 |
| 94 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.50325915 |
| 95 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.49910393 |
| 96 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48874107 |
| 97 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.48638871 |
| 98 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.48105191 |
| 99 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.45725953 |
| 100 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.45699060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.30633188 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 6.48835892 |
| 3 | MP0005360_urolithiasis | 5.93059929 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 5.85760887 |
| 5 | MP0005365_abnormal_bile_salt | 5.77423619 |
| 6 | MP0003195_calcinosis | 4.74888988 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.52275784 |
| 8 | MP0003252_abnormal_bile_duct | 4.29992654 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.30831300 |
| 10 | MP0003868_abnormal_feces_composition | 3.28831195 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.74832120 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.70310074 |
| 13 | MP0009697_abnormal_copulation | 2.55188782 |
| 14 | MP0005332_abnormal_amino_acid | 2.42412899 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.11471295 |
| 16 | MP0010368_abnormal_lymphatic_system | 1.99104197 |
| 17 | MP0009840_abnormal_foam_cell | 1.88435935 |
| 18 | MP0000609_abnormal_liver_physiology | 1.87733091 |
| 19 | MP0004782_abnormal_surfactant_physiolog | 1.83015566 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.78838392 |
| 21 | MP0002876_abnormal_thyroid_physiology | 1.69384978 |
| 22 | MP0001764_abnormal_homeostasis | 1.52845742 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.35706157 |
| 24 | MP0001661_extended_life_span | 1.30663383 |
| 25 | MP0002132_abnormal_respiratory_system | 1.30464366 |
| 26 | MP0005670_abnormal_white_adipose | 1.18957849 |
| 27 | MP0005408_hypopigmentation | 1.18887705 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.14559048 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.11192876 |
| 30 | MP0000598_abnormal_liver_morphology | 1.06185592 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.04044753 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02596007 |
| 33 | MP0009764_decreased_sensitivity_to | 1.02019465 |
| 34 | MP0009053_abnormal_anal_canal | 0.99812149 |
| 35 | MP0009763_increased_sensitivity_to | 0.93184222 |
| 36 | MP0000604_amyloidosis | 0.91742678 |
| 37 | MP0001915_intracranial_hemorrhage | 0.90304351 |
| 38 | MP0008469_abnormal_protein_level | 0.88426682 |
| 39 | MP0009642_abnormal_blood_homeostasis | 0.86110799 |
| 40 | MP0005376_homeostasis/metabolism_phenot | 0.84929022 |
| 41 | MP0002971_abnormal_brown_adipose | 0.82073846 |
| 42 | MP0003690_abnormal_glial_cell | 0.78079878 |
| 43 | MP0005451_abnormal_body_composition | 0.76115574 |
| 44 | MP0005395_other_phenotype | 0.75925454 |
| 45 | MP0003186_abnormal_redox_activity | 0.75446357 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 0.72262153 |
| 47 | MP0005187_abnormal_penis_morphology | 0.70926996 |
| 48 | MP0002282_abnormal_trachea_morphology | 0.70547231 |
| 49 | MP0002168_other_aberrant_phenotype | 0.68540882 |
| 50 | MP0005464_abnormal_platelet_physiology | 0.66014662 |
| 51 | MP0009785_altered_susceptibility_to | 0.64404717 |
| 52 | MP0005023_abnormal_wound_healing | 0.63910549 |
| 53 | MP0003638_abnormal_response/metabolism_ | 0.61491228 |
| 54 | MP0008872_abnormal_physiological_respon | 0.60734684 |
| 55 | MP0003879_abnormal_hair_cell | 0.60558206 |
| 56 | MP0005164_abnormal_response_to | 0.60202612 |
| 57 | MP0005058_abnormal_lysosome_morphology | 0.58864781 |
| 58 | MP0005535_abnormal_body_temperature | 0.58386091 |
| 59 | MP0008874_decreased_physiological_sensi | 0.58299442 |
| 60 | MP0005083_abnormal_biliary_tract | 0.58155109 |
| 61 | MP0004883_abnormal_blood_vessel | 0.58033488 |
| 62 | MP0002078_abnormal_glucose_homeostasis | 0.57502724 |
| 63 | MP0001881_abnormal_mammary_gland | 0.52906165 |
| 64 | MP0005266_abnormal_metabolism | 0.52900734 |
| 65 | MP0000249_abnormal_blood_vessel | 0.52749958 |
| 66 | MP0001851_eye_inflammation | 0.51712040 |
| 67 | MP0005166_decreased_susceptibility_to | 0.51025891 |
| 68 | MP0005334_abnormal_fat_pad | 0.50968113 |
| 69 | MP0004130_abnormal_muscle_cell | 0.50254200 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 0.47713181 |
| 71 | MP0003011_delayed_dark_adaptation | 0.45793035 |
| 72 | MP0003075_altered_response_to | 0.43769130 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.42969784 |
| 74 | MP0001958_emphysema | 0.41885502 |
| 75 | MP0002249_abnormal_larynx_morphology | 0.38280953 |
| 76 | MP0005448_abnormal_energy_balance | 0.33160371 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.32430017 |
| 78 | MP0005647_abnormal_sex_gland | 0.31166552 |
| 79 | MP0009115_abnormal_fat_cell | 0.30703300 |
| 80 | MP0001845_abnormal_inflammatory_respons | 0.30459954 |
| 81 | MP0000639_abnormal_adrenal_gland | 0.29666944 |
| 82 | MP0001756_abnormal_urination | 0.29665789 |
| 83 | MP0002295_abnormal_pulmonary_circulatio | 0.28871242 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 0.28297847 |
| 85 | MP0001545_abnormal_hematopoietic_system | 0.28297847 |
| 86 | MP0006036_abnormal_mitochondrial_physio | 0.28255243 |
| 87 | MP0000566_synostosis | 0.28193524 |
| 88 | MP0003436_decreased_susceptibility_to | 0.28007015 |
| 89 | MP0005220_abnormal_exocrine_pancreas | 0.27410828 |
| 90 | MP0003953_abnormal_hormone_level | 0.26574627 |
| 91 | MP0002128_abnormal_blood_circulation | 0.25099866 |
| 92 | MP0004272_abnormal_basement_membrane | 0.24020804 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.23572072 |
| 94 | MP0002419_abnormal_innate_immunity | 0.23510655 |
| 95 | MP0008873_increased_physiological_sensi | 0.22984734 |
| 96 | MP0003718_maternal_effect | 0.22559632 |
| 97 | MP0003705_abnormal_hypodermis_morpholog | 0.21930206 |
| 98 | MP0005025_abnormal_response_to | 0.21854031 |
| 99 | MP0000920_abnormal_myelination | 0.21437267 |
| 100 | MP0002135_abnormal_kidney_morphology | 0.20637595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.80713323 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 8.90013949 |
| 3 | Abnormality of complement system (HP:0005339) | 8.50313305 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.98593971 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 7.50417239 |
| 6 | Conjugated hyperbilirubinemia (HP:0002908) | 7.00666432 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 6.73783577 |
| 8 | Joint hemorrhage (HP:0005261) | 6.34355650 |
| 9 | Glomerulonephritis (HP:0000099) | 6.10359402 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.46757524 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 5.42436915 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 5.09821592 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.02779371 |
| 14 | Spontaneous abortion (HP:0005268) | 4.73070863 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.72952069 |
| 16 | Xanthomatosis (HP:0000991) | 4.64935194 |
| 17 | Nephritis (HP:0000123) | 4.42331476 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.36447377 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 4.19481462 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.80247976 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.36239574 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.34803664 |
| 23 | Fat malabsorption (HP:0002630) | 3.31392890 |
| 24 | Gingival bleeding (HP:0000225) | 3.22936612 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.20923065 |
| 26 | Hyperammonemia (HP:0001987) | 3.05739554 |
| 27 | Hyperglycinemia (HP:0002154) | 2.86013671 |
| 28 | Hypercholesterolemia (HP:0003124) | 2.84328023 |
| 29 | Abnormality of nucleobase metabolism (HP:0010932) | 2.74492194 |
| 30 | Thrombophlebitis (HP:0004418) | 2.74173907 |
| 31 | Epidermoid cyst (HP:0200040) | 2.73304794 |
| 32 | Osteomalacia (HP:0002749) | 2.66847392 |
| 33 | Mitral stenosis (HP:0001718) | 2.66099461 |
| 34 | Hepatocellular carcinoma (HP:0001402) | 2.65592044 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.63162320 |
| 36 | Purpura (HP:0000979) | 2.59501179 |
| 37 | Vascular calcification (HP:0004934) | 2.59181953 |
| 38 | Delayed CNS myelination (HP:0002188) | 2.55777803 |
| 39 | Hyperbilirubinemia (HP:0002904) | 2.52409134 |
| 40 | Hemorrhage of the eye (HP:0011885) | 2.50979006 |
| 41 | Fair hair (HP:0002286) | 2.47858369 |
| 42 | Pulmonary embolism (HP:0002204) | 2.46977009 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.45346959 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 2.45346959 |
| 45 | Rickets (HP:0002748) | 2.45163808 |
| 46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.45104518 |
| 47 | Menorrhagia (HP:0000132) | 2.40511177 |
| 48 | Steatorrhea (HP:0002570) | 2.40471068 |
| 49 | Reduced antithrombin III activity (HP:0001976) | 2.40123331 |
| 50 | Abnormality of serum amino acid levels (HP:0003112) | 2.35581136 |
| 51 | Cardiovascular calcification (HP:0011915) | 2.28468451 |
| 52 | Neonatal hypoglycemia (HP:0001998) | 2.24588459 |
| 53 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.22090719 |
| 54 | Cholelithiasis (HP:0001081) | 2.11422776 |
| 55 | Joint swelling (HP:0001386) | 2.09864474 |
| 56 | Hyperglycinuria (HP:0003108) | 2.07188116 |
| 57 | Complement deficiency (HP:0004431) | 10.5847876 |
| 58 | Deep venous thrombosis (HP:0002625) | 10.0266555 |
| 59 | Metabolic acidosis (HP:0001942) | 1.99852930 |
| 60 | Elevated alkaline phosphatase (HP:0003155) | 1.99470455 |
| 61 | Arthropathy (HP:0003040) | 1.97701659 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 1.97435306 |
| 63 | Abnormality of iron homeostasis (HP:0011031) | 1.95243134 |
| 64 | Myocardial infarction (HP:0001658) | 1.94961357 |
| 65 | Increased serum ferritin (HP:0003281) | 1.93905876 |
| 66 | Cholecystitis (HP:0001082) | 1.90138059 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 1.90138059 |
| 68 | Ketosis (HP:0001946) | 1.88685353 |
| 69 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88564063 |
| 70 | Gout (HP:0001997) | 1.87436068 |
| 71 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.84072889 |
| 72 | Abnormality of purine metabolism (HP:0004352) | 1.83531419 |
| 73 | Epistaxis (HP:0000421) | 1.83489798 |
| 74 | Interstitial pulmonary disease (HP:0006530) | 1.81689223 |
| 75 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81423440 |
| 76 | Generalized hypopigmentation of hair (HP:0011358) | 1.79011419 |
| 77 | Irritability (HP:0000737) | 1.78336898 |
| 78 | Abnormality of the Achilles tendon (HP:0005109) | 1.77096903 |
| 79 | Gangrene (HP:0100758) | 1.76081720 |
| 80 | Abnormality of vitamin metabolism (HP:0100508) | 1.73310284 |
| 81 | Skin nodule (HP:0200036) | 1.72654806 |
| 82 | Hyperphosphaturia (HP:0003109) | 1.71817773 |
| 83 | Cerebral palsy (HP:0100021) | 1.65636169 |
| 84 | Alkalosis (HP:0001948) | 1.62001566 |
| 85 | Abnormal delivery (HP:0001787) | 1.59604569 |
| 86 | Hypophosphatemic rickets (HP:0004912) | 1.57348850 |
| 87 | Abnormality of urine glucose concentration (HP:0011016) | 1.56419844 |
| 88 | Glycosuria (HP:0003076) | 1.56419844 |
| 89 | Blue irides (HP:0000635) | 1.56121878 |
| 90 | Abnormal biliary tract physiology (HP:0012439) | 1.54958609 |
| 91 | Bile duct proliferation (HP:0001408) | 1.54958609 |
| 92 | Amyloidosis (HP:0011034) | 1.54920949 |
| 93 | Atrioventricular block (HP:0001678) | 1.53589102 |
| 94 | Bifid scrotum (HP:0000048) | 1.50475163 |
| 95 | Poikilocytosis (HP:0004447) | 1.49323993 |
| 96 | Enlarged kidneys (HP:0000105) | 1.49020854 |
| 97 | Increased mean platelet volume (HP:0011877) | 1.48949908 |
| 98 | Pancreatitis (HP:0001733) | 1.48876880 |
| 99 | Increased serum pyruvate (HP:0003542) | 1.46754732 |
| 100 | Hydroxyprolinuria (HP:0003080) | 1.42882454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 4.59319622 |
| 2 | ERN1 | 4.41408163 |
| 3 | PDK2 | 3.23230037 |
| 4 | EPHA3 | 3.00900172 |
| 5 | RIPK1 | 3.00588035 |
| 6 | MST1R | 2.99189904 |
| 7 | PIK3CG | 2.92646655 |
| 8 | TYK2 | 2.66885212 |
| 9 | FGFR3 | 2.60258749 |
| 10 | TRIB3 | 2.21927542 |
| 11 | PIK3CA | 2.18532191 |
| 12 | TGFBR2 | 1.84991288 |
| 13 | PRKACG | 1.80896165 |
| 14 | EPHB1 | 1.75102153 |
| 15 | SIK1 | 1.71923969 |
| 16 | JAK1 | 1.67224462 |
| 17 | NLK | 1.65121456 |
| 18 | PDPK1 | 1.60983508 |
| 19 | PRKAA2 | 1.60289801 |
| 20 | TAOK3 | 1.60175649 |
| 21 | NEK9 | 1.59108427 |
| 22 | BCKDK | 1.54700584 |
| 23 | FER | 1.49580107 |
| 24 | LATS1 | 1.47740654 |
| 25 | MAPK11 | 1.45134123 |
| 26 | ZAP70 | 1.44522563 |
| 27 | MET | 1.30044521 |
| 28 | IGF1R | 1.29219162 |
| 29 | MAP3K3 | 1.27071002 |
| 30 | MAP2K4 | 1.26674725 |
| 31 | PRPF4B | 1.21891841 |
| 32 | TIE1 | 1.18393414 |
| 33 | NTRK3 | 1.13614073 |
| 34 | MAP3K6 | 1.11378616 |
| 35 | TBK1 | 1.10870352 |
| 36 | ICK | 1.08435415 |
| 37 | PDK1 | 1.05736965 |
| 38 | JAK2 | 1.03991664 |
| 39 | AKT3 | 1.03683744 |
| 40 | PKN2 | 1.03599560 |
| 41 | MAP3K2 | 1.00711605 |
| 42 | MAP3K1 | 1.00118234 |
| 43 | CAMKK2 | 0.99457050 |
| 44 | RET | 0.97303516 |
| 45 | CDK6 | 0.97100853 |
| 46 | ERBB2 | 0.89658456 |
| 47 | ABL2 | 0.89534634 |
| 48 | BRSK2 | 0.87861592 |
| 49 | PRKCG | 0.80469137 |
| 50 | PRKCZ | 0.75815546 |
| 51 | MYLK | 0.73090707 |
| 52 | PRKG1 | 0.72810654 |
| 53 | TNK2 | 0.71930075 |
| 54 | MAPK12 | 0.67732027 |
| 55 | PRKACA | 0.65415573 |
| 56 | MAPKAPK3 | 0.61811139 |
| 57 | IRAK1 | 0.61807709 |
| 58 | KDR | 0.61254223 |
| 59 | GSK3A | 0.60736145 |
| 60 | MAPK7 | 0.60271980 |
| 61 | PDGFRB | 0.59340449 |
| 62 | CSF1R | 0.58921676 |
| 63 | MAP3K12 | 0.56118088 |
| 64 | STK38 | 0.55569165 |
| 65 | PRKAA1 | 0.54217269 |
| 66 | SGK3 | 0.52505571 |
| 67 | PRKCA | 0.50047008 |
| 68 | SGK1 | 0.50044525 |
| 69 | PRKACB | 0.50009992 |
| 70 | SGK2 | 0.49120336 |
| 71 | NEK6 | 0.48731075 |
| 72 | DAPK2 | 0.48376247 |
| 73 | MAP2K3 | 0.48080336 |
| 74 | ERBB4 | 0.47708371 |
| 75 | BLK | 0.47520541 |
| 76 | PINK1 | 0.47099502 |
| 77 | SGK494 | 0.46487398 |
| 78 | SGK223 | 0.46487398 |
| 79 | SRC | 0.45441280 |
| 80 | LRRK2 | 0.45013669 |
| 81 | INSRR | 0.44811782 |
| 82 | RPS6KA3 | 0.44505021 |
| 83 | MAPK4 | 0.44481791 |
| 84 | PDGFRA | 0.43494028 |
| 85 | CSNK1D | 0.43017592 |
| 86 | CSNK1E | 0.42145658 |
| 87 | PTK6 | 0.41523433 |
| 88 | MAP2K6 | 0.41100122 |
| 89 | STK38L | 0.41081565 |
| 90 | CAMKK1 | 0.41038110 |
| 91 | PRKCB | 0.40935657 |
| 92 | MAP3K13 | 0.38262014 |
| 93 | MAPK3 | 0.37927825 |
| 94 | EPHA2 | 0.37734724 |
| 95 | MAP3K7 | 0.36798103 |
| 96 | RPS6KB1 | 0.34356331 |
| 97 | MAP3K5 | 0.32781247 |
| 98 | EPHA4 | 0.32740092 |
| 99 | TRPM7 | 0.32520000 |
| 100 | PRKD1 | 0.32501205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.40872655 |
| 2 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.22678002 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.20522219 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.86446763 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.45422089 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41127132 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 3.32521903 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.80379645 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.79320991 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.63074765 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.61873464 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.57773101 |
| 13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.56063484 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.51283943 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.44584551 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43409313 |
| 17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.33772294 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.06335361 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.05241459 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.93468703 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.80588733 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.78042903 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77377875 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.73608389 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66773818 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.59325189 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48226912 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.44663155 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41983386 |
| 30 | Prion diseases_Homo sapiens_hsa05020 | 1.40122716 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.38455480 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33640077 |
| 33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29897177 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.25126538 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23861732 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19799927 |
| 37 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.19750361 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10745761 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08868534 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01855654 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.01782232 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 0.91726114 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89931625 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.89915691 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.83528857 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83429552 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.82566790 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82354961 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79535482 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77355240 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69639897 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69420709 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69375124 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55103911 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54410601 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52118269 |
| 57 | * Pertussis_Homo sapiens_hsa05133 | 0.41957769 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.41349106 |
| 59 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39871102 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37695065 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30660480 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28708351 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28599305 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.26874338 |
| 65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20366883 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20091934 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19362336 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18761419 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17553678 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15294737 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12445985 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.09936539 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.09801255 |
| 74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.08315777 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.07922245 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.05846107 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.04660015 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.04531512 |
| 79 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.04209389 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03492295 |
| 81 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01755405 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2261411 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2158936 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2107749 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2098771 |
| 86 | Phagosome_Homo sapiens_hsa04145 | -0.2051694 |
| 87 | Lysosome_Homo sapiens_hsa04142 | -0.1920957 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1603433 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1596861 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1567252 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1502607 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1391611 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0934378 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0929137 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0395035 |
| 96 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0390542 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0135488 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0135236 |
| 99 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0102871 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0072311 |

